U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Pediatric Advisory Committee
  5. Products and Briefing Materials for the April 12, 2016 Meeting of the Pediatric Advisory Committee
  1. Pediatric Advisory Committee

Products and Briefing Materials for the April 12, 2016 Meeting of the Pediatric Advisory Committee

Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.

  1. ACIPHEX SPRINKLE (rabeprazole Sodium)
  2. FLULAVAL QUADRIVALENT (Influenza Vaccine)
  3. FLULAVAL (Influenza Vaccine)
  4. FLUZONE QUADRIVALENT (Influenza Vaccine)
  5. MYCAMINE (micafungin sodium)
  6. NOXAFIL (posaconazole)
  7. PRECEDEX (dexmedetomidine hydrochloride)
  8. SABRIL (vigabatrin)
  9. SEROQUEL (quetiapine fumarate) and SEROQUEL XR (quetiapine fumarate extended-release)
  10. SKYLA (levonorgestrel-releasing intrauterine system)
  11. SYMBYAX (fluoxetine hydrochloride and olanzapine)
  12. VYVANSE CAPSULES (lisdexamfetamine dimesylate)
  13. XELODA (capecitabine)

Pediatric HDE Devices

  1. IMPELLA RP SYSTEM
  2. LIPOSORBER LA-15 SYSTEM
  3. MEDTRONIC ACTIVA DYSTONIA THERAPY

 

Back to Top